Endometrial Cancer of the Uterine Isthmus: A Cohort Study on Clinicopathological Features and Prognosis
Cancer Medicine · 2026-06 · 15 (6)
DOI: 10.1002/cam4.72015 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Cancer Medicine, online erschienen am 17.06.2026. Verfasst von Hao Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Tengzhou Central People's Hospital, Tengzhou, China. Hauptthemen laut MEDLINE: Endometrial Neoplasms. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: This research supported the Scientific Research Fund of Shandong Province 469 Medical Association YXH2022ZX02148..
Abstract (Originalsprache)
Objective
The study compared the clinicopathologic characteristics and prognosis of patients with uterine isthmus cancer to those with uterine fundus cancer. The aim was to identify risk variables associated with the prognosis of patients with isthmus cancer.
Methods
In the SEER cohort, 584 endometrial cancer patients were included: 91 in the isthmus group and 493 in the fundus group. Data for this retrospective study were collected from the Surveillance, Epidemiology, and End Results (SEER) database and the registry of a provincial hospital. SEER included individuals diagnosed with endometrial cancer between 2000 and 2018. Patients were divided into two groups according to the primary site code for endometrial cancer: Isthmus and fundus. Chi‐square tests were used to compare the population characteristics. STROBE Protocol was followed.
Results
Isthmus cancers were younger, more advanced, often non‐endometrioid adenocarcinomas, and more likely to receive adjuvant therapy ( p < 0.05). The 3‐year overall survival rate for isthmus cancer was significantly lower than for fundus cancer ( p = 0.016). Uterine isthmus cancer in the hospital cohort accounted for 2.0% (9/455) of the diagnosed endometrial cancers. All patients survived without recurrence or metastasis and were in good physical condition.
Conclusion
The research assessed the prognostic impact of the uterine isthmus and the clinical and pathological features of uterine isthmus cancer, and the associated risk factors affecting prognosis. Uterine isthmus cancer demonstrates a higher stage, a stronger tendency for adjuvant therapy, and a more unfavorable prognosis when compared to fundus carcinoma. The international evidence is diverse on this issue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ultrasound, Tengzhou Central People's Hospital, Tengzhou, China.
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Key Laboratory of Laparoscopic Technology, the First Affiliated Hosp…
- Department of Gynecology, The Second Affiliated Hospital of Shandong First Medical University, Taian, China.
- Jining Medical University, Jining, China.
- International Healthcare Management Research and Development Centre (IHM-RDC), The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China.
- Atlantica Instituto Universitario, Health Management, Oeiras, Portugal.
ORCID-Profile: Paulo Moreira
Förderung
- This research supported the Scientific Research Fund of Shandong Province 469 Medical Association YXH2022ZX02148.
Zitieren
APA
Wang, H., Xiao, P., Zhu, C., Zhou, J., Yang, C., Moreira, P., & Yan, L. (2026). Endometrial Cancer of the Uterine Isthmus: A Cohort Study on Clinicopathological Features and Prognosis. Cancer Medicine, 15(6). https://doi.org/10.1002/cam4.72015
Vancouver
Wang H, Xiao P, Zhu C, Zhou J, Yang C, Moreira P, et al. Endometrial Cancer of the Uterine Isthmus: A Cohort Study on Clinicopathological Features and Prognosis. Cancer Medicine. 2026;15(6). doi:10.1002/cam4.72015
BibTeX
@article{Wang2026,
author = {Wang, Hao and Xiao, Peijie and Zhu, Chendi and Zhou, Jinxia and Yang, Chunhua and Moreira, Paulo and Yan, Li},
title = {Endometrial Cancer of the Uterine Isthmus: A Cohort Study on Clinicopathological Features and Prognosis},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {6},
doi = {10.1002/cam4.72015}
}
EUVIMED